Compliance to Adjuvant Chemotherapy of Patients Who Underwent Surgery for Rectal Cancer: Report from a Multi-institutional Research Network.

Giulio M MariDario MaggioniJacopo CrippaAndrea T M CostanziMauro A ScottiVittorio GiardiniMattia GaranciniEugenio CocozzaGiacomo BorroniIlaria BenzoniMario MartinottiLuigi TotaroMatteo OrigiMichele MazzolaGiovanni FerrariPietro AchilliAntonio ZiccarelliAntonio MartinoRoberto PetriFrancesca BottaVincenzo BagnardiGiacomo PuglieseAntonello ForgioneRaffaele Pugliesenull null

Published in: World journal of surgery (2020)

The present multicenter investigation reports a low compliance rate to adjuvant chemotherapy after rectal resection for cancer. Multidisciplinary teams should focus on future effort to improve compliance for these patients.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
squamous cell carcinoma
radiation therapy
patient reported
squamous cell
adverse drug
network analysis
drug induced